We are live on ! Find out more
PAVMW

PAVmed Inc. Warrant
PAVMW

Delisted

PAVMW was delisted on the 28th of January, 2022.

Back to rankings

3 hedge funds and large institutions have $278K invested in PAVmed Inc. Warrant in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more capital invested

Capital invested by funds: $130K → $278K (+$148K)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

25% less funds holding

Funds holding: 4 → 3 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
+$36.7K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$847
Name Holding Trade Value Shares
Change 		Change in
Stake
WAM
1
Wolverine Asset Management
Illinois
$272K +$36.7K +13,370 +22%
UBS Group
2
UBS Group
Switzerland
$5K -$847 -309 -20%
AF
3
Allworth Financial
California
$1K – – –

PAVMW Hedge Fund Activity: Q3 2021 in Review

3 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Warrant (PAVMW) for Q3 2021, worth a combined $278K — up 114% from $130K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of PAVMW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was Wolverine Asset Management, adding an estimated $36.7K. The largest seller was UBS Group, cutting an estimated $847.

  • 3 institutional investors held PAVmed Inc. Warrant (PAVMW) as of Q3 2021, down from 4 in Q2 2021.
  • Funds reported $278K of PAVmed Inc. Warrant stock for Q3 2021, up 114% quarter-over-quarter.
  • 0 funds opened new PAVmed Inc. Warrant positions in Q3 2021 and 1 closed out, a net change of -1 holder.
  • The largest PAVmed Inc. Warrant buyer in Q3 2021 was Wolverine Asset Management, an estimated $36.7K added.
  • The largest PAVmed Inc. Warrant seller in Q3 2021 was UBS Group, an estimated $847 sold.

Based on aggregated 13F filings for Q3 2021.